Introduction: The hepatitis B virus (HBV) is one of the major causes of morbidity and mortality in the world. Few up-to-date data on this disease are available in developing countries, including Togo. The aim of this study was to estimate the prevalence of hepatitis B among women of childbearing age in the Kara region of Togo. Methods: A cross-sectional study was carried out from 23 to 25 September 2022 during a fairground campaign. Data were collected using a standardised questionnaire. HBV screening was performed using “SD-BIOLINE HBsAg WB” rapid immunochromatographic tests. HBV prevalence was reported with its 95% confidence interval (CI). Regression analyses were performed to identify factors associated with HBV infection. Results: A total of 327 women were enrolled, with a median age of 34 years and an interquartile range of [25 - 43]. Nearly half (49.5%) of the women had had their first sexual intercourse before the age of 18 and 2.1% had at least 2 sexual partners at the time of the survey. The majority (91.7%) had not used a condom the last time they had sex. The prevalence of hepatitis B was 10.4% (95% CI: 7.5 - 14.2]). In multivariable analysis, having had sexual intercourse for the first time after the age of 18 (ORa = 0.17; 95% CI [0.06 - 0.43]; p < 0.001), and secondary (ORa = 0.24; 95% CI [0.09 - 0.61]; p = 0. 003) or university education (ORa = 0.25; 95% CI [0.77 - 0.86]; p = 0.028) were protective factors against HBV infection compared with those who had primary education or had never attended school. Conclusion: The results of this study underline the importance of monitoring the prevalence of hepatitis B in women of childbearing age, and of implementing targeted prevention and screening measures to eliminate mother-to-child transmission of HBV.
References
[1]
WHO: World Health Organization (2008) Guidelines Approved by the Guidelines Review Committee.
[2]
World Health Organization (2021) Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021. https://www.who.int/publications-detail-redirect/9789240027077
[3]
Edmunds, W.J., Medley, G.F., Nokes, D.J., Hall, A.J. and Whittle, H.C. (1997) The Influence of Age on the Development of the Hepatitis B Carrier State. Proceedings of the Royal Society of London Series B: Biological Sciences, 253, 197-201. https://doi.org/10.1098/rspb.1993.0102
[4]
World Health Organization (2016) Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards Ending Viral Hepatitis. https://www.who.int/publications-detail-redirect/WHO-HIV-2016.06
[5]
Find the Missing Millions Advocacy Resource. https://www.worldhepatitisalliance.org/missing-millions/
[6]
Kafeero, H.M., Ndagire, D., Ocama, P., Kudamba, A., Walusansa, A. and Sendagire, H. (2021) Prevalence and Predictors of Hepatitis B Virus (HBV) Infection in East Africa: Evidence from a Systematic Review and Meta-Analysis of Epidemiological Studies Published from 2005 to 2020. Archives of Public Health, 79, Article No. 167. https://doi.org/10.1186/s13690-021-00686-1
[7]
Coffie, P.A., Patassi, A., Doumbia, A., Bado, G., Messou, E., Minga, A., et al. (2017) Changes in Viral Hepatitis B Screening Practices over Time in West African HIV Clinics. Médecine et Maladies Infectieuses, 47, 394-400. https://doi.org/10.1016/j.medmal.2017.04.011
[8]
Lavanchy, D. (2004) Hepatitis B Virus Epidemiology, Disease Burden, Treatment, and Current and Emerging Prevention and Control Measures. Journal of Viral Hepatitis, 11, 97-107. https://doi.org/10.1046/j.1365-2893.2003.00487.x
[9]
McMahon, B.J. (2009) The Natural History of Chronic Hepatitis B Virus Infection. Hepatology, 49, S45-S55. https://doi.org/10.1002/hep.22898
[10]
Beasley, R.P., Trepo, C., Stevens, C.E. and Szmuness, W. (1977) The e Antigen and Vertical Transmission of Hepatitis B Surface Antigen. American Journal of Epidemiology, 105, 94-98. https://doi.org/10.1093/oxfordjournals.aje.a112370
[11]
Kao, J.H. (2015) Hepatitis B Vaccination and Prevention of Hepatocellular Carcinoma. Best Practice & Research Clinical Gastroenterology, 29, 907-917. https://doi.org/10.1016/j.bpg.2015.09.011
[12]
Omeje, K.N., Ibekwe, R.C., Ojukwu, J.O., Una, A.F. and Ibe, B.C. (2017) Risk Factors for Hepatitis B Surface Antigenaemia among Secondary School Students in Abakaliki, South Eastern Nigeria. Nigerian Journal of Paediatrics, 44, 14-21. https://doi.org/10.4314/njp.v44i1.3
[13]
Ministère de la Santé du Togo (2010) Programme Elargi de Vaccination du Togo. Rapport d’activités de l’année 2009.
[14]
Halatoko, W.A., Patassi, A., Yanogo, P., Banla, L.I., Koba, A., Issa, Z., et al. (2019) Risk Factors of Hepatitis B Virus Surface Antigen Carriage and Serological Profile of HBsAg Carriers in Lomé Togo, 2016. BMC Public Health, 19, Article No. 32. https://doi.org/10.1186/s12889-018-6320-x
[15]
Ekouevi, D.K., Larrouy, L., Gbeasor-Komlanvi, F.A., Mackiewicz, V., Tchankoni, M.K., Bitty-Anderson, A.M., et al. (2020) Prevalence of Hepatitis B among Childbearing Women and Infant Born to HBV-Positive Mothers in Togo. BMC Infectious Diseases, 20, Article No. 839. https://doi.org/10.1186/s12879-020-05574-7
[16]
Antuamwine, B.B., Herchel, E.D. and Bawa, E.M. (2022) Comparative Prevalence of Hepatitis B Virus Infection among Pregnant Women Accessing Free Maternal Care in a Tertiary Hospital in Ghana. PLOS ONE, 17, e0263651. https://doi.org/10.1371/journal.pone.0263651
[17]
Olakunde, B.O., Adeyinka, D.A., Olakunde, O.A., Uthman, O.A., Bada, F.O., Nartey, Y.A., et al. (2021) A Systematic Review and Meta-Analysis of the Prevalence of Hepatitis B Virus Infection among Pregnant Women in Nigeria. PLOS ONE, 16, e0259218. https://doi.org/10.1371/journal.pone.0259218
[18]
Ekouevi, D.K., Thomas, A., Sewu, D., Lawson-Ananissoh, L., Tchounga, B., Salou, M., et al. (2017) Prevalence of Hepatitis B among Students from the University of Lomé, Togo in 2015. Open Journal of Epidemiology, 7, 262-272. https://doi.org/10.4236/ojepi.2017.73020
[19]
Banla, A.K., Gani, K.T., Halatoko, W.A., et al. (2015) Prevalence of the Surface Antigen of Hepatitis B Virus among Youth Aged 15 to 24 in TOGO in 2010. Journal of Infectious Diseases & Therapy, 3, Article ID: 1000238. http://www.esciencecentral.org/journals/prevalence-of-the-surface-antigen-of-hepatitis-b-virus-among-youth-aged-15-to-24-in-togo-in-2010-2090-7214-1000238.php?aid=61745 https://doi.org/10.4172/2332-0877.1000238
[20]
Stevens, C.J., Gillman, A.S., Gardiner, C.K., Montanaro, E.A., Bryan, A.D. and Conner, M. (2019) Feel Good Now or Regret It Later? The Respective Roles of Affective Attitudes and Anticipated Affective Reactions for Explaining Health-Promoting and Health Risk Behavioral Intentions. Journal of Applied Social Psychology, 49, 331-348. https://doi.org/10.1111/jasp.12584
[21]
Mawouma, A.R.N., Djoulatou, A.H., Komnang, E.O. and Kimessoukie, E.O. (2022) Facteurs associés à l’infection de l’hépatite B chez les femmes enceintes dans les formations sanitaires du district de santé de Mokolo/Région de l’Extrême-Nord Cameroun. The Pan African Medical Journal, 41, Article 61.
[22]
Martinson, F.E.A., Weigle, K.A., Royce, R.A., Weber, D.J., Suchindran, C.M. and Lemon, S.M. (1998) Risk Factors for Horizontal Transmission of Hepatitis B Virus in a Rural District in Ghana. American Journal of Epidemiology, 147, 478-487. https://doi.org/10.1093/oxfordjournals.aje.a009474
